Abstract
Nosocomial respiratory tract infections are the leading type of nosocomial infections. Despite the development of new antibiotic therapies, they are associated with an increased morbidity and mortality. Patients with comorbidities are especially predisposed to acquire these infections, as are patients exposed to respiratory therapy. Aspiration of colonized secretions from the oropharynx is the main mechanism of infection development. Barrier techniques to reduce aspiration and antimicrobial agents to alter bacterial flora are important in preventing pneumonia episodes. The initial institution of an adequate antibiotic regimen is a determinant of outcome. Nosocomial pneumonias are often difficult to treat due to antibiotic-resistant bacteria. Antibiotic policies are crucial in avoiding a progression in antibiotic resistance.
| Original language | English |
|---|---|
| Pages (from-to) | 1004-1014 |
| Number of pages | 11 |
| Journal | Microbes and Infection |
| Volume | 6 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Sept 2004 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antibiotics
- Diagnosis
- Nosocomial infections
- Nosocomial pneumonia
- Prevention
Fingerprint
Dive into the research topics of 'Nosocomial lung infections in adult intensive care units'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver